300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
Social Impact
InsurTech
Oil and Gas
Retail
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
Social Network
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
LGBT
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Celebrity
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Climate
Hardware
Biotech
Impact
Proptech
Enterprise
Transportation
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Brazil
Kyrgyzstan
LATAM
Oman
Africa
Oceania
Puerto Rico
Poland
Cameroon
Guernsey
Sudan
Andorra
Colombia
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Seychelles
Moldova
Paraguay
Botswana
Japan
Ireland
Canada
United Kingdom
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
United States
Germany
India
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Argentina
Europe
Cyprus
Bangladesh
Qatar
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Bahamas
Ecuador
Bolivia
Algeria
Belize
Finland
Italy
Faroe Islands
Belarus
Estonia
Hungary
Grenada
Israel
Jersey
Bahrain
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Peru
Mongolia
Slovenia
Ukraine
San Marino
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
METIS innovative, VC Fund

METIS innovative

VC Fund

Miami Beach, United States

METIS innovative is a VC fund in Miami Beach focused on Medical and Medical Device. Metis Innovative was formed in 2017 as an investment vehicle for promising early stage medical devices and technology in the neurosciences. Founded by two prominent neurosurgeons in academic practice and a veteran of capital accrual for investment opportunities, the firm’s mission is to identify and invest in unique, well positioned companiesfocused on scientific breakthroughs.

Total investments:
7
Last investment:
Lead investor:
0%

Last updated:

Industries METIS innovative invests in

MedicalMedical DeviceRoboticsHealth CareNeuroscience

Stages METIS innovative invests in

Series ASeedSeries BSeries CSeries D

Countries METIS innovative invests in

United StatesCanada

Round sizes

Series A $19M–$27M

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

4 more contacts available

Round size

Series A
$19M–$27M

Investment Focus

Industry

  • Medical 3 (43%)
  • Medical Device 2 (29%)
  • Robotics 1 (14%)
  • Health Care 1 (14%)
  • Neuroscience 1 (14%)
See all 8 industries →

Stage

  • Series A 2 (29%)
  • Seed 1 (14%)
  • Series B 1 (14%)
  • Series C 1 (14%)
  • Series D 1 (14%)

Country

  • United States 2 (29%)
  • Canada 1 (14%)

Team

NameTitleInvestmentsLinksEmail
Brian Sidman
Brian Sidman Co-Founder, Principal; Co-Founder, Principal
Co-Founder, Principal; Co-Founder, Principal Total investments: 0 Find email

Investments

CompanyDescriptionRoundLinks
Phantom Neuro Phantom Neuro
Phantom Neuro develops innovative muscle-machine interfaces that enhance robotic limb rehabilitation. The company focuses on creating solutions that improve mobility for users by integrating neurotechnology with robotic systems. Through its minimally invasive approach, Phantom Neuro aims to facilitate precise control of robotic limbs, allowing formore natural movement and better user experiences. The company is committed to advancing the field of neurotechnology, providing valuable tools for rehabilitation and improving the quality of life for individuals with mobility challenges. Phantom Neuro also explores various applications of its technologies, contributing to the broader field of assistive robotics. $19M / Series A / Apr 15, 2025
Fluid Biomed Fluid Biomed
Fluid Biotech is a Calgary based company that aims to develop the next generation of stents to improve patient well-being and realise better health and quality of life through innovation. $27M / Series A / Dec 16, 2024
Synchron Synchron
Synchron manufactures and markets a medical device that can be delivered to the brain with a catheter to record neuron signals that might be used to control an advanced prosthetic. $75M / Series C / Dec 16, 2022
Synchron Synchron
Synchron manufactures and markets a medical device that can be delivered to the brain with a catheter to record neuron signals that might be used to control an advanced prosthetic. $75M / Series C / Dec 15, 2022
Fluid Biomed Fluid Biomed
Fluid Biotech is a Calgary based company that aims to develop the next generation of stents to improve patient well-being and realise better health and quality of life through innovation. $4.7M / Seed / Aug 11, 2021
Synchron Synchron
Synchron manufactures and markets a medical device that can be delivered to the brain with a catheter to record neuron signals that might be used to control an advanced prosthetic. $40M / Series B / Jun 03, 2021
Synchron Synchron
Synchron manufactures and markets a medical device that can be delivered to the brain with a catheter to record neuron signals that might be used to control an advanced prosthetic. $200M / Series D

Co-Investors

Khosla Ventures Khosla Ventures 4 deals together
Neurotechnology Investors 4 deals together
Forepont Capital Partners Forepont Capital Partners 3 deals together
ID8 Investments ID8 Investments 3 deals together
University of Melbourne University of Melbourne 3 deals together
ARCH Venture Partners ARCH Venture Partners 2 deals together

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
Social Impact
InsurTech
Oil and Gas
Retail
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
Social Network
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
LGBT
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Celebrity
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Climate
Hardware
Biotech
Impact
Proptech
Enterprise
Transportation
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Brazil
Kyrgyzstan
LATAM
Oman
Africa
Oceania
Puerto Rico
Poland
Cameroon
Guernsey
Sudan
Andorra
Colombia
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Seychelles
Moldova
Paraguay
Botswana
Japan
Ireland
Canada
United Kingdom
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
United States
Germany
India
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Argentina
Europe
Cyprus
Bangladesh
Qatar
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Bahamas
Ecuador
Bolivia
Algeria
Belize
Finland
Italy
Faroe Islands
Belarus
Estonia
Hungary
Grenada
Israel
Jersey
Bahrain
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Peru
Mongolia
Slovenia
Ukraine
San Marino
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does METIS innovative invest in?

METIS innovative invests primarily in Medical, Medical Device and Robotics startups, most often at Series A and Seed stage. Most of the 7 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is METIS innovative's check size?

METIS innovative typically joins rounds of $19M–$27M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds METIS innovative participates in.

How do I contact METIS innovative?

Public channels for METIS innovative include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at METIS innovative?

The team at METIS innovative includes Brian Sidman (Co-Founder, Principal; Co-Founder, Principal). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
METIS innovative METIS innovative Find emails